logo
ProjectActive

Jointown Pharmaceuticals Group Co. Ltd

The status, timeline and source of this project. A free account opens every field.

Source: Deutsche Investitions- und Entwicklungsgesellschaft (DEG)

Jointown Pharmaceutical Group (JOIN), established in 1991, is China´s largest private and fourth-largest pharmaceutical distributor in general. It is also the only private Top 10 company in this field. Its core business is pharmaceutical (medicine and small medical devices) distribution for wholesaler and retail chains, hospitals and clinics, individual oharmacies and others (online etc.).The inve

Status
Prospective
Sector
Commercial, Hospital
Location
China
Updated
19 Nov 2026
Source
Deutsche Investitions- und Entwicklungsgesellschaft (DEG)

ConstructChat

Ask ConstructChat about Jointown Pharmaceuticals Group Co. Ltd

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Jointown Pharmaceuticals Group Co. Ltd” is an infrastructure initiative in the Commercial sector, located in China. Taiyo aggregates data on it from Deutsche Investitions- und Entwicklungsgesellschaft (DEG).

Participants

Not available for this record.

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Jointown Pharmaceutical Group (JOIN), established in 1991, is China´s largest private and fourth-largest pharmaceutical distributor in general. It is also the only private Top 10 company in this field. Its core business is pharmaceutical (medicine and small medical devices) distribution for wholesaler and retail chains, hospitals and clinics, individual oharmacies and others (online etc.).The investment proposal entails a parallel financing from DEG and ADB for up to EUR 60m. The amount is split evenly between DEG and ADB. The funds are to be used to increase delivery capacity through building and upgrading 3 warehouses in Tangshang, JIangshu and Hainan and to finance working capital. This undertaking will improve supply of essential medicine to China´s remote and underserved areas. DEG´s engagement will controbite to the creation of up to 5000 new jobs - a lot of 18 percent growth for the company. It will furthermore contribute to breaking up the local oligopolistic market in pharma distribution, by enhancing JOIN´s market share as a private sector company. Environmental and social sustainability will be improved further through the implementation of an action plan.

Original sector

Services

Budget

Location

Country

China

Source

Source

Deutsche Investitions- und Entwicklungsgesellschaft (DEG)

URL

More Details

Record type

Project

Sector

Commercial, Hospital

Article published date

2024-05-29

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project